Susquehanna Fundamental Investments’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-19,986
| Closed | -$9.69M | – | 1026 |
|
2025
Q1 | $9.69M | Buy |
19,986
+15,886
| +387% | +$7.7M | 0.14% | 187 |
|
2024
Q4 | $1.65M | Buy |
+4,100
| New | +$1.65M | 0.02% | 580 |
|
2024
Q2 | $21M | Buy |
+44,819
| New | +$21M | 0.48% | 52 |
|
2023
Q3 | – | Sell |
-6,072
| Closed | -$2.14M | – | 597 |
|
2023
Q2 | $2.14M | Hold |
6,072
| – | – | 0.08% | 236 |
|
2023
Q1 | $1.91M | Sell |
6,072
-5,530
| -48% | -$1.74M | 0.04% | 382 |
|
2022
Q4 | $3.35M | Sell |
11,602
-16,411
| -59% | -$4.74M | 0.06% | 366 |
|
2022
Q3 | $8.11M | Buy |
+28,013
| New | +$8.11M | 0.14% | 212 |
|
2021
Q2 | – | Sell |
-10,768
| Closed | -$2.31M | – | 1790 |
|
2021
Q1 | $2.31M | Sell |
10,768
-26,862
| -71% | -$5.77M | 0.04% | 589 |
|
2020
Q4 | $8.89M | Buy |
+37,630
| New | +$8.89M | 0.16% | 168 |
|